Saturday, December 3, 2022


Vios Fertility Institute – St. Louis and TMRW Life Sciences Launches State-of-the-Art Cryo Management Technology for Fertility Specimens

TMRW’s technology provides the world’s first and only fully automated specimen management platform (CryoRobot) that identifies, tracks, and manages frozen eggs and embryos - central to almost every IVF journey.  Vios Fertility Institute’s Chicago lab was the first in the world to adopt this revolutionary technology in early 2021.  

Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical

Omeros received approximately $126 million in cash at closing. In addition, Omeros retains and is entitled to collect the full amount of its accounts receivable outstanding as of today’s closing.

Curocell, Breaks Ground on ‘CAR-T Manufacturing GMP Facility’

The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-meter site of CAR-T Center.

Neoss Launches NeoGenix XP™

This exciting product line will add new dimensions to Neoss existing Bone Regeneration offering, providing an enhanced offering of Bone materials and membranes.

Health Logic Interactive Announces Proof-of-Concept Test Results and Advancement of its Lab-on-Chip Technology

With these developments, Health Logic Interactive is preparing for its pre-submission meeting with the United States Food and Drug Administration.

ENPICOM Announces Expansion of IGX Platform

This integration unlocks new antibody discovery workflows like performing structural analysis of proteins of interest and annotating important liability characteristics to select antibody candidates with good developability properties.

By using this website you agree to accept Medical Device News Magazine Privacy Policy